Edition:
United Kingdom

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.46USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$0.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
46,439
52-wk High
$3.28
52-wk Low
$0.37

Chart for

About

ContraVir Pharmaceuticals, Inc. is focused on curing hepatitis B through the combination of direct and indirect acting antiviral compounds. Its two assets tenofovir exalidex, or TXL, and CRV431 have complementary mechanisms of action and have shown potential synergy against hepatitis B virus (HBV). TXL is designed to deliver... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $48.36
Shares Outstanding(Mil.): 78.00
Dividend: --
Yield (%): --

Financials

  CTRV.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.29 -- --
ROI: -126.93 0.28 15.02
ROE: -- 0.94 16.60

Earnings vs. Estimates